ASHION ANALYTICS, LLC
PHOENIX, AZ

In 2014, Translational Genomics Research Institute’s (TGen’s) CLIA laboratory became Ashion Analytics, LLC. Ashion Analytics™ was originally developed using the clinical genomic sequencing and analysis technology utilized in the world’s first clinical studies for personalized cancer treatment. We continue to work with TGen® to provide clinical genomic sequencing for several important clinical studies. We are experts at Next-Generation Sequencing-based clinical laboratory services, derived from our pedigree from the pioneering precision medicine work at the Translational Genomics Research Institute® (TGen®) in Phoenix. In 2014, Translational Genomics Research Institute’s (TGen’s) CLIA laboratory became Ashion Analytics, LLC. Ashion Analytics™ was originally developed using the clinical genomic sequencing and analysis technology utilized in the world’s first clinical studies for personalized cancer treatment. We continue to work with TGen® to provide clinical genomic sequencing for several important clinical studies. We are experts at Next-Generation Sequencing-based clinical laboratory services, derived from our pedigree from the pioneering precision medicine work at the Translational Genomics Research Institute® (TGen®) in Phoenix. At Ashion®, we provide personalized options for today’s cancer treatment. Ashion®, a TGen® Specialty Lab, is a CAP accredited and CLIA-certified clinical genomics testing laboratory committed to accelerating the adoption of precision medicine in mainstream oncology, leveraging years of scientific and clinical experience. We offer a wide range of testing capabilities to assist our Physicians, Health Systems, Research and Commercial partners to provide precision cancer treatments. Ashion Analytics employees do not diagnose or treat disease. Any information provided by the Ashion Analytics website is for educational or business purposes only and any medical decisions should be made in consultation with a licensed medical professional.